Jisoo, a renowned South Korean singer and member of the highly popular K-pop group Blackpink, has received a positive COVID-19 test result. As a result, she will not be able to join the group’s upcoming stage performances in Japan, according to their management agency’s announcement on Thursday.
The official statement was shared on the fan community forum Weverse by YG Entertainment. The agency informed fans that Jisoo had tested positive for the virus on June 1st, after experiencing mild cold symptoms for two days. “We regret to inform you that Jisoo, a member of Blackpink, has tested positive for COVID-19 on June 1st,” the statement read.
The agency further explained that Jisoo had taken a self-test on May 30th after displaying minor cold symptoms. Although the initial result was negative, a subsequent test on June 1st confirmed the positive diagnosis.
As a consequence of her illness, the 28-year-old vocalist will be unable to participate in the upcoming [BORN PINK] World Tour shows scheduled to take place in Osaka, Japan over the weekend. However, the remaining three members of Blackpink, Jennie, Lisa, and Rose, will carry on with the performances.
While Jisoo was determined to fulfill her commitment to the devoted Blackpink fans who have been eagerly awaiting the shows, she ultimately decided to prioritize her health and the well-being of everyone involved by not participating in the concert.
“Consequently, only JENNIE, LISA, and ROSÉ, the three remaining members, will be taking part in the [BORN PINK] World Tour concerts in Osaka, Japan on June 3rd and 4th. We are fully aware of the excitement and the high expectations of the fans for this performance, and we will exert our utmost effort to deliver a memorable concert as planned. We kindly request your unwavering support,” YG Entertainment added.
Blackpink, formed in 2016, has gained immense popularity for their chart-topping hits like “How You Like That,” “Boombayah,” “Ddu-du Ddu-du,” and “Pink Venom.”